BREAKING: Target Test Prep releases Brand New 2026 On Demand GMAT prep course

Redeem

Target Test Prep · GMAT

Choose how you want to prepare

Learn live with an expert or move at your own pace. Every option includes the complete TTP study system.

★★★★★5.0559 reviews
Vote for Target Test Prep, Newsweek Readers’ Choice Awards 2026
NEWSWEEK READERS’ CHOICE 2026

BIG NEWS! Target Test Prep has been nominated, and they’d love your vote!

TTP has worked incredibly hard to build the best test prep experience possible, and winning Newsweek’s 2026 Readers’ Choice Award for Best Test Prep would mean a lot to them. If TTP has helped you, they’d be incredibly grateful for your vote. You can vote once each day through September 9.

Vote for TTP
GMATLiveTeach 7 seats left
Chris Peckover
NEXT LIVE COHORT

Oct 13 to Jan 7, 2027

with Chris Peckover

Schedule
Tue, Thu · 8:00 to 10:00 PM ET
Included
40 live hours + 6 months of GMAT OnDemand
  • Live instruction and real-time questions
  • Class recordings and assigned practice
View class & enroll
Limited cohort · enrollment openTarget Test Prep
EALiveTeach 5 seats left
Logan Thompson
EXECUTIVE ASSESSMENT

Sep 6 to Dec 6, 2026

with Logan Thompson

Schedule
Sun · 9:30 AM to 12:30 PM ET
Included
40 hours of live online classes plus six months of access to the complete TTP EA OnDemand course.
  • 165+ EA Score Guarantee
  • 4,100+ Quant, Verbal, and Integrated Reasoning practice questions
  • 400+ hours of in-depth video lessons
  • 3,000+ step-by-step video solutions
View EA class & enroll
Limited cohort · enrollment openTarget Test Prep
GMATOnDemand Start anytime
SELF-PACED MASTERCLASS

Target Test Prep GMAT OnDemand

Complete access from day one. Study on your schedule.

715+ score guarantee
$0to start then $127/mo
  • Personalized study plan and analytics
  • Thousands of lessons and practice questions

Compare the format, schedule, and included access before enrolling. Prices and seat counts shown reflect the supplied offer details.

Strengthen Question

Expert replies
by kamalakarthi » Fri Aug 04, 2017 12:01 pm
Hi, This question is from Veritas Prep question bank.

In this question, can you help me understand why option E is not correct. My line of analysis.

Conclusion ::There must be something qualitatively different b/w 2 types of mem loss.

Strengthen ::Something should say that fundamentally something is different.

I thought since age is different, the results are different. What am I missing in bigger picture ? Can you please help.


Image
Join the discussion
Source: — Critical Reasoning |

by DavidG@VeritasPrep » Fri Aug 04, 2017 12:51 pm
kamalakarthi wrote:Hi, This question is from Veritas Prep question bank.

In this question, can you help me understand why option E is not correct. My line of analysis.

Conclusion ::There must be something qualitatively different b/w 2 types of mem loss.

Strengthen ::Something should say that fundamentally something is different.

I thought since age is different, the results are different. What am I missing in bigger picture ? Can you please help.


Image
The problem is that we want to know whether there's a difference in the type of brain impairment. Knowing that there's a difference in age between the two groups doesn't tell us this. (And the age gap is something we likely could have surmised on our own. People who are diagnosed with Alzheimer's tend to be older than people who suffer brain injuries from car crashes or high-impact sports.)

Think of it this way: the study is suggesting that the two groups are fundamentally different. If we want to strengthen the conclusion we're deriving from the study, we want it to be the case that the study was well-conducted. In other words, we don't want to have to worry about confounding variables. If for example, Person A suffers from early-stage Alzheimer's and has mild memory impairment and Person B was just in a devastating car wreck and suffered a severe traumatic brain injury, the fact that the drug worked for Person A and not for Person B wouldn't tell us whether the drug works better for Alzheimer's than it does for acute injuries. It would simply confirm that Person A came in with a less severe condition that was more amenable to treatment. So that's the big issue: was the drug tested on subjects who had similar memory impairment.
Veritas Prep | GMAT Instructor

Veritas Prep Reviews
Save $100 off any live Veritas Prep GMAT Course
Join the discussion